Quest Diagnostics EVP Catherine Doherty to retire July 2027, shifts to new EVP role Nov 1, 2026
QUEST DIAGNOSTICS INC
Catherine T. Doherty will retire in July 2027; effective November 1, 2026 she moves to Executive Vice President covering health systems, the Corewell Health joint venture, and Project Nova.
Base salary unchanged at $650,000; annual incentive target stays at 80% of base salary under the Senior Management Incentive Plan.
Committee approved an equity award with a November 3, 2026 grant date and $1,200,000 target value, allocated 100% to restricted stock units.
The equity award carries terms substantially the same as 2026 annual long-term incentive awards granted to other Quest senior executives.
Project Nova is described as the company's multi-year effort to modernize its 'Order to Cash' business processes, related IT infrastructure and enabling technologies.
Until then, effective November 1, 2026, Ms. Doherty will transition to a new role as Executive Vice President with responsibilities including health systems, the Company’s joint venture with Corewell Health, and Project Nova, the Company’s multi-year project to modernize its “Order to Cash” business processes, which includes the related information technology infrastructure and underlying enabling technologies.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.85
Catherine T. Doherty retired as Executive Vice President at QUEST DIAGNOSTICS INC.
Action
retired
Role
Executive Vice President
Exact text from the filing
On October 6, 2026, Quest Diagnostics Incorporated (the “Company”) announced that Catherine T. Doherty will retire in July 2027.
Catherine T. Doherty changed role as Executive Vice President at QUEST DIAGNOSTICS INC.
Action
transitioned
Role
Executive Vice President
Exact text from the filing
Until then, effective November 1, 2026, Ms. Doherty will transition to a new role as Executive Vice President with responsibilities including health systems, the Company’s joint venture with Corewell Health, and Project Nova, the Company’s multi-year project to modernize its “Order to Cash” business processes, which includes the related information technology infrastructure and underlying enabling technologies.
This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.